Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 5 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 927 Neoplasms 609 Breast Neoplasms 606 Colorectal Neoplasms 457 Neoplasm Metastasis 395 Ovarian Neoplasms 327 Prostatic Neoplasms 314 Melanoma 311 Lung Neoplasms 295 Multiple Myeloma 290 Recurrence 278 Squamous Cell Carcinoma of Head and Neck 246 Stomach Neoplasms 229 Pancreatic Neoplasms 227 Leukemia, Myeloid, Acute 221 Triple Negative Breast Neoplasms 190 Endometrial Neoplasms 190 Carcinoma, Renal Cell 181 Lymphoma, Non-Hodgkin 179 Carcinoma, Hepatocellular 179 Small Cell Lung Carcinoma 165 Leukemia, Lymphocytic, Chronic, B-Cell 156 Advanced Solid Tumors 155 Lymphoma, Follicular 149 Urinary Bladder Neoplasms 139 Lymphoma, Large B-Cell, Diffuse 138 Lymphoma 137 Advanced Solid Tumor 137 Uterine Cervical Neoplasms 134 Head and Neck Neoplasms 134

Interventions

Saline Solution 1 Deoxycholic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Lipoma × 1 year × Clear all

NCT07237425 2025-12-04

Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma

Glonova Pharma Co., Ltd

Phase 1 Recruiting

Lipoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡